Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alejandro Berlin

Showing results (141-150 of 221) with videos related to

Pageof 23
Sort By:
Radiation Oncology (London, England)|September 20, 2023
Clinical and dosimetric outcomes of image-guided, dose-painted radiotherapy in muscle invasive bladder cancerInmaculada Navarro-Domenech, Shinthujah Arulanantham, Zhihui Amy Liu, et al.
Neuro-Oncology|September 29, 2018
Outcomes following stereotactic radiosurgery for small to medium-sized brain metastases are exceptionally dependent upon tumor size and prescribed doseFabio Y Moraes, Jeff Winter, Eshetu G Atenafu, et al.
BJU International|September 14, 2020
Can post-treatment free PSA ratio be used to predict adverse outcomes in recurrent prostate cancer?Hanan Goldberg, Rachel Glicksman, Dixon Woon, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|May 9, 2022
Exploring the value of using patient-oriented MRI reports in clinical practice - a pilot studyNathan Perlis, Antonio Finelli, Mike Lovas, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|May 27, 2022
Correction to: Exploring the value of using patient‑oriented MRI reports in clinical practice - a pilot studyNathan Perlis, Antonio Finelli, Mike Lovas, et al.
European Urology Focus|July 5, 2020
The Suggested Unique Association Between the Various Statin Subgroups and Prostate CancerHanan Goldberg, Faizan K Mohsin, Refik Saskin, et al.
Oncotarget|November 22, 2014
NBN gain is predictive for adverse outcome following image-guided radiotherapy for localized prostate cancerAlejandro Berlin, Emilie Lalonde, Jenna Sykes, et al.
Current Oncology (Toronto, Ont.)|January 22, 2021
Clinicopathologic and Treatment Features of Long-Term Surviving Brain Metastasis PatientsArchya Dasgupta, Jayson Co, Jeff Winter, et al.
International Journal of Radiation Oncology, Biology, Physics|September 1, 2018
Genomic Classifier for Guiding Treatment of Intermediate-Risk Prostate Cancers to Dose-Escalated Image Guided Radiation Therapy Without Hormone TherapyAlejandro Berlin, Jure Murgic, Ali Hosni, et al.
Neurosurgery|April 14, 2025
Neoadjuvant Stereotactic Radiosurgery for Large Brain Metastases: An International, Multicenter, Single-Arm Phase II TrialRanda Higazy, Dianna Li, Ruth Lau, et al.
Pageof 23

Showing results (141-150 of 221) with videos related to

Sort By:
Pageof 23
Radiation Oncology (London, England)|September 20, 2023
Clinical and dosimetric outcomes of image-guided, dose-painted radiotherapy in muscle invasive bladder cancerInmaculada Navarro-Domenech, Shinthujah Arulanantham, Zhihui Amy Liu, et al.
Neuro-Oncology|September 29, 2018
Outcomes following stereotactic radiosurgery for small to medium-sized brain metastases are exceptionally dependent upon tumor size and prescribed doseFabio Y Moraes, Jeff Winter, Eshetu G Atenafu, et al.
BJU International|September 14, 2020
Can post-treatment free PSA ratio be used to predict adverse outcomes in recurrent prostate cancer?Hanan Goldberg, Rachel Glicksman, Dixon Woon, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|May 9, 2022
Exploring the value of using patient-oriented MRI reports in clinical practice - a pilot studyNathan Perlis, Antonio Finelli, Mike Lovas, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|May 27, 2022
Correction to: Exploring the value of using patient‑oriented MRI reports in clinical practice - a pilot studyNathan Perlis, Antonio Finelli, Mike Lovas, et al.
European Urology Focus|July 5, 2020
The Suggested Unique Association Between the Various Statin Subgroups and Prostate CancerHanan Goldberg, Faizan K Mohsin, Refik Saskin, et al.
Oncotarget|November 22, 2014
NBN gain is predictive for adverse outcome following image-guided radiotherapy for localized prostate cancerAlejandro Berlin, Emilie Lalonde, Jenna Sykes, et al.
Current Oncology (Toronto, Ont.)|January 22, 2021
Clinicopathologic and Treatment Features of Long-Term Surviving Brain Metastasis PatientsArchya Dasgupta, Jayson Co, Jeff Winter, et al.
International Journal of Radiation Oncology, Biology, Physics|September 1, 2018
Genomic Classifier for Guiding Treatment of Intermediate-Risk Prostate Cancers to Dose-Escalated Image Guided Radiation Therapy Without Hormone TherapyAlejandro Berlin, Jure Murgic, Ali Hosni, et al.
Neurosurgery|April 14, 2025
Neoadjuvant Stereotactic Radiosurgery for Large Brain Metastases: An International, Multicenter, Single-Arm Phase II TrialRanda Higazy, Dianna Li, Ruth Lau, et al.
Pageof 23